Skip to main content

Peer Review reports

From: A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol

Original Submission
7 Jun 2024 Submitted Original manuscript
14 Aug 2024 Author responded Author comments - David A. Palma
Resubmission - Version 2
14 Aug 2024 Submitted Manuscript version 2
Publishing
16 Aug 2024 Editorially accepted
7 Sep 2024 Article published 10.1186/s12904-024-01548-7

You can find further information about peer review here.

Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us